Analyst: Alexion Pharmaceuticals Pipeline Is Undervalued
March 11, 2015 at 16:55 PM EDT
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) is getting insufficient credit from investors for its development pipeline, an analyst ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.